The Medicines Company Announces New Patent Issuance for Angiomax(R) (Marketwire)
The Medicines Company Announces New Patent Issuance for Angiomax(R) (Marketwire)
PARSIPPANY, NJ–(Marketwire – September 2, 2009) – The Medicines Company ( NASDAQ : MDCO ) today announced that the United States Patent and Trademark Office (PTO) issued a new U.S. patent No. 7,582,727 (’727 patent). The ’727 patent relates to a more consistent and improved Angiomax drug product. The new patent has been submitted to the U.S. Food and Drug Administration (FDA) for listing in the …